XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Revenue        
Total revenue $ 227,117 $ 180,123 $ 578,815 $ 510,397
Operating expenses        
Cost of services, excluding depreciation and amortization 147,473 121,823 424,303 402,106
General and administrative expenses 21,813 16,270 45,476 39,660
Depreciation and amortization 4,671 4,674 13,105 14,004
Total expenses 173,957 142,767 482,884 455,770
Income from operations 53,160 37,356 95,931 54,627
Other (expense) income        
Income (loss) from equity method investments 132 403 (3,680) 3,291
Gain on sale of equity method investment 2,193 0 2,193 99,647
Interest expense (967) (2,466) (4,343) (8,007)
Interest income 420 752 1,331 2,544
Unrealized (loss) gain on investments (60,943) 0 22,826 0
Other income (expense) 500 130 (14,080) 1,514
Total other (expense) income, net (58,665) (1,181) 4,247 98,989
(Loss) income before (benefit from) provision for income taxes (5,505) 36,175 100,178 153,616
(Benefit from) provision for income taxes (120) 10,751 31,575 44,204
Net (loss) income (5,385) 25,424 68,603 109,412
Net (loss) income attributable to noncontrolling interest (39,664) 8,711 8,515 81,603
Net income attributable to Apollo Medical Holdings, Inc. $ 34,279 $ 16,713 $ 60,088 $ 27,809
Earnings per share – basic (in dollars per share) $ 0.77 $ 0.46 $ 1.38 $ 0.77
Earnings per share – diluted (in dollars per share) $ 0.74 $ 0.45 $ 1.33 $ 0.75
Capitation, net        
Revenue        
Total revenue $ 149,059 $ 135,032 $ 438,350 $ 416,402
Risk pool settlements and incentives        
Revenue        
Total revenue 59,923 30,916 94,146 54,155
Management fee income        
Revenue        
Total revenue 9,652 8,707 26,345 26,212
Fee-for-service, net        
Revenue        
Total revenue 7,260 3,737 14,968 9,434
Other income        
Revenue        
Total revenue $ 1,223 $ 1,731 $ 5,006 $ 4,194